We added 47 PCTs and 26 US patent applications focused on psychedelics to our tracker in the month of November 2023. New entries came from the likes of MindMed, DemeRx, CaaMTech, Mydecine, Enveric, atai, Cybin, and even Paul Stamets. In November, we also began regularly tracking prosecution status updates for the 800+ US patent applications in our database. As a result, we are now able to provide…

Source

Previous articleMAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics
Next articlePT475 – End-of-Life Care and Psychedelics: The Role of a Death Doula